Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. Aug 15, 2017; 9(8): 333-340
Published online Aug 15, 2017. doi: 10.4251/wjgo.v9.i8.333
Published online Aug 15, 2017. doi: 10.4251/wjgo.v9.i8.333
Table 1 Patient characteristics n (%)
Adeno | SCC | Total | |
No. of patients | 841 | 132 | 973 |
Median age (range) | 62 (22-84) | 60 (37-77) | 61 (22-84) |
Gender | |||
Male | 730 (87) | 95 (72) | 825 (85) |
Female | 111 (13) | 37 (28) | 148 (15) |
Performance status1 | |||
0 | 223 (27) | 33 (25) | 256 (26) |
1 | 489 (58) | 75 (57) | 564 (58) |
2 | 127 (15) | 23 (18) | 150 (15) |
Sub-site | |||
Oesophagus | 438 (52) | 117 (89) | 555 (57) |
OGJ | 403 (48) | 15 (11) | 418 (43) |
Extent of disease2 | |||
Locally advanced | 219 (26) | 36 (27) | 255 (26) |
Metastatic | 622 (74) | 95 (72) | 717 (74) |
Location of metastases | |||
Liver | 340 (46) | 46 (35) | 386 (40) |
Peritoneum | 41 (5) | 4 (3) | 45 (4.5) |
Lung | 136 (16) | 18 (14) | 154 (16) |
- Citation: Davidson M, Chau I, Cunningham D, Khabra K, Iveson T, Hickish T, Seymour M, Starling N. Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer. World J Gastrointest Oncol 2017; 9(8): 333-340
- URL: https://www.wjgnet.com/1948-5204/full/v9/i8/333.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i8.333